Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
166 results about "Cardiac monitoring" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Cardiac monitoring generally refers to continuous or intermittent monitoring of heart activity, generally by electrocardiography, with assessment of the patient's condition relative to their cardiac rhythm. It is different from hemodynamic monitoring, which monitors the pressure and flow of blood within the cardiovascular system. The two may be performed simultaneously on critical heart patients. Cardiac monitoring with a small device worn by an ambulatory patient (one well enough to walk around) is known as ambulatory electrocardiography (such as with a Holter monitor, wireless ambulatory ECG, or an implantable loop recorder). Transmitting data from a monitor to a distant monitoring station is known as telemetry or biotelemetry.
Methods and apparatus for determining work performed by an individual from measured physiological parameters
InactiveUS20050107723A1Promote productionPhysical therapies and activitiesPerson identificationAccelerometer dataGas analysis
Methods and apparatus for gathering and processing data sensed on an individual from portable heart monitors and accelerometers aligned along three orthogonal axes determine substantially equivalent oxygen consumption information during an individual's physical activities without requiring gas-flow or gas-analysis equipment. Such information promotes calculations of physiological energy expenditures, and analyses of the accelerometer data associated with a specific sensing location on an individual's body provide indication of the particular physical activity for selecting appropriate scaling factors and filtering requirements in analyzing the data to determine various parameters indicative of the individual's expenditure of physiological energy, and other health-oriented factors.
Owner:TELECOM MEDICAL
Non-invasive cardiac monitor and methods of using continuously recorded cardiac data
ActiveUS20070249946A1Improve fidelityElectrocardiographyLocal control/monitoringCardiac monitoringNon invasive
Embodiments of the invention provide methods of obtaining continuous cardiac information from a mammal. First, attach a self-contained, wearable, portable continuous cardiac monitor to the mammal to create a chamber containing electrodes used to detect cardiac signals from the mammal. Next, continuously detect without analyzing the cardiac signals from the mammal for at least 24 hours. Next, store information related to substantially all detected cardiac signals in the cardiac monitor.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Cardiac arrhythmia detector using ECG waveform-factor and its irregularity
InactiveUS6480734B1Avoiding unnecessary shockSignificant energy savingElectrocardiographyHeart defibrillatorsVentricular tachycardiaCardiac monitoring
A cardiac monitor is provided that monitors the condition of the heart of a cardiac patient and generates signals indicating one of several conditions, such as supraventricular tachycardia, ventricular tachycardia and ventricular fibrillation. In order to generate these signals, the ECG from the patient is analyzed to determine a cardiac interval and heart rate, as well as a waveform factor and a waveform factor irregularity. The waveform factor is derived from the average of the ECG amplitudes during a cardiac interval and the peak value of the ECG during the same interval. Preferably, a running average is calculated over several intervals. This waveform factor is then used to detect shockable ventricular arrhythmia. The waveform factor irregularity is indicative of the variability of the waveform factor and is used to differentiate between ventricular tachycardia and ventricular defibrillation.
Owner:ZOLL MEDICAL CORPORATION
Non-invasive cardiac monitor and methods of using continuously recorded cardiac data
ActiveUS20070255153A1Improve fidelityElectrocardiographyLocal control/monitoringAdhesiveCardiac monitoring
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Long-term cutaneous cardiac monitoring
InactiveUS20130116533A1Continuous monitoringElectrocardiographySensorsElectricityElectronic controller
A system for long-term non-invasive heart monitoring includes (1) a disposable unit that has built-in electrodes, a built-in wire antenna, a watertight chamber that can be opened and closed, and an adhesive surface for cutaneous mounting; (2) an electronic controller that can acquire, process and store physiological signals, and can be fitted into the disposable unit to establish electrical contact with the built-in electrodes; and (3) a portable communication unit that can wirelessly communicate bi-directionally with the electronic controller, and further communicate bi-directionally with a remote service center.
Owner:BIOTRONIK SE & CO KG
Non-invasive cardiac monitor and methods of using continuously recorded cardiac data
ActiveUS20070225611A1Improve fidelityElectrocardiographyLocal control/monitoringCardiac monitoringNon invasive
Embodiments of the present invention provide a method of analyzing cardiac information by collecting a plurality of self-contained, wearable, portable cardiac monitors each of the cardiac monitors electronically storing at least 24 hours of continuously detected and unanalyzed cardiac signals from a mammal. Next, retrieving cardiac information stored in each of the plurality of self-contained portable cardiac monitors. Next, forwarding retrieved cardiac information.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
System and method for monitoring or treating nervous system disorders
A medical device system that includes a brain monitoring element, cardiac monitoring element and a processor. The processor is configured to receive a brain signal from the brain monitoring element and a cardiac signal from the cardiac monitoring element. The processor is further configured to compare the brain signal to the cardiac signal. A method of comparing a brain signal to a cardiac signal is also provided.
Owner:MEDTRONIC INC
Cardiac activation sequence monitoring for ischemia detection
InactiveUS20060116593A1Convenient wireless communicationElectrocardiographyHeart stimulatorsImplantable ElectrodesCardiac cycle
Cardiac monitoring and / or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and / or trend ischemia using cardiac activation sequence information. Ischemia detection may involve sensing composite cardiac signals using implantable electrodes, and performing a signal separation that produces one or more cardiac activation signal vectors associated with one or more cardiac activation sequences. A change in the signal vector may be detected using subsequent separations. The change may be an elevation or depression of the ST segment of a cardiac cycle or other change indicative of myocardial ischemia, myocardial infarction, or other pathological change. The change may be used to predict, quantify, and / or qualify an event such as an arrhythmia, a myocardial infarction, or other pathologic change. Information associated with the vectors may be stored and used to track the vectors.
Owner:CARDIAC PACEMAKERS INC
Personal physiograph
InactiveUS6978169B1Facilitating deployment and widespread useEasy to moveElectrocardiographySensorsCare personnelMedicine
Disclosed are systems and methods which provide a relatively small, preferably easily transportable, interpretive biotelemetric monitor, such as may utilize platforms developed for use as personal digital assistants, adapted for use by non-health care personnel. A preferred embodiment biotelemetric monitor comprises a self-contained EKG monitor providing ICU cardiac monitoring with accurate real-time diagnostic heart rhythm analysis directly to the wearer. Preferred embodiment biotelemetric monitors implement multiple interactive screens to guide a user through a series of screens to help understand the monitored conditions. Moreover, the biotelemetric monitor may operate to analyze and interpret the monitored data to thereby present information with respect to the probable implications of the monitored condition and / or make recommendations which may be useful to the patient at that time. Preferably, communications functionality is included to facilitate communication between the biotelemetric monitor and a host system.
Owner:BIOMEDICA DIAGNOSTICS INC
Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes
InactiveUS7509170B2Heart stimulatorsDiagnostic recording/measuringImplantable ElectrodesCardiac monitoring
Cardiac monitoring and / or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed for automatic capture verification using cardiac activation sequence information. Devices and methods sense composite cardiac signals using implantable electrodes. A source separation is performed using the composite signals. One or more signal vectors are produced that are associated with all or a portion of one or more cardiac activation sequences based on the source separation. A cardiac response to the pacing pulses is classified using characteristics associated with cardiac signal vectors and the signals associated with the vectors. Further embodiments may involve classifying the cardiac response as capture or non-capture, fusion or intrinsic cardiac activity. The characteristics may include an angle or an angle change of the cardiac signal vectors, such as a predetermined range of angles of the one or more cardiac signal vectors.
Owner:CARDIAC PACEMAKERS INC
Method and system for extracting cardiac parameters from plethysmographic signals
This invention provides methods and systems for extracting cardiac parameters, including ventricular wall motion, from a plethysmographic signal is provided. Additionally, the invention provides a wide range of uses and system configurations for cardiac monitoring, including ambulatory uses, uses for stress testing, uses for monitoring first responder personnel, and the like.
Owner:ADIDAS
Cardiac monitoring apparatus and method
InactiveUS6881191B2Improve signal-to-noise ratioEasy to cleanElectrocardiographyInertial sensorsPulse rateCardiac monitoring
A monitor includes cardiac and movement sensors 36, 34 responsive to a user's heart beat and a user's movement. The monitor includes a processor coupled to the sensors for generating heart-rate or other cardiac data and user movement or activity data. These data can be stored in a memory and used to analyse the relationship between heart rate and physical exertion.
Owner:CAMNTECH
Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes
Cardiac monitoring and / or stimulation methods and systems provide for monitoring, diagnosing, defibrillation and pacing therapies, or a combination of these capabilities, including cardiac systems incorporating or cooperating with neuro-stimulating devices, drug pumps, or other therapies. Embodiments of the present invention relate generally to implantable medical devices employing automated cardiac activation sequence monitoring and / or tracking for arrhythmia discrimination. Embodiments of the invention are directed to devices and methods involving sensing a plurality of composite cardiac signals using a plurality of implantable electrodes. A source separation is performed using the sensed plurality of composite cardiac signals and the separation produces one or more cardiac signal vectors associated with one or more cardiac activation sequences that is indicative of ischemia. A change of the one or more cardiac signal vectors is detected using the one or more cardiac signal vectors. Cardiac arrhythmias are discriminated using the one or more cardiac signal vectors.
Owner:CARDIAC PACEMAKERS INC
Mechanical function marker channel for cardiac monitoring and therapy control
The implantable medical device (IMD) system disclosed here utilizes one or more cardiac sensors that measure mechanical characteristics of the heart, such as left ventricular acceleration or right ventricular pressure. The raw sensor data is collected and processed by the IMD, which derives one or more mechanical event marker signals from features, traits, and characteristics of the sensor data waveforms. The mechanical event marker signals are wirelessly transmitted to an external monitor device for display.
Owner:MEDTRONIC INC
Wireless ECG system
InactiveUS7197357B2Increased comfort and mobilityEasy to useElectrocardiographySensorsCardiac monitoringEngineering
A cardiac monitoring system and, more particularly, a wireless electrocardiograph (ECG) system. The present invention detects electrical signals from a patient's heart and transmits the signals digitally to a remote base station via telemetry. The base station converts the digital signals back to an analog electrical signals that can be read by an ECG monitor.
Owner:LIFESYNC
Heart Monitor
A heart monitor for use as a non-invasive screening tool for identifying potential atrial fibrillation in patients comprises a sensor for producing an output waveform of the patient's actual sinus rhythm, a processing unit arranged to store the normalised waveform of an ideal sinus rhythm and to compare the actual and ideal sinus rhythm waveforms and to produce an output dependant on the difference on a display. The value of the output is indicative of whether the patient is atrial fibrillation or other cardiac arrhythmia.
Owner:MELYS DIAGNOSTICS
Pulse rate, pressure and heart condition monitoring glasses
Battery and solar cell powered health glasses monitor the condition of a heart's vital signs. Light emitting diodes (LED's) emit light into human temples. Photodiodes capture light reflected back from the pulsing blood. The amount of reflected light corresponds to the pulse rate. Embedded circuitry cleans and amplifies the signals, which are transmitted to light emitters located in the glasses. The same signals may be transmitted to a remote receiver to be processed and / or stored. Rhythm and shape of the pulse rate, processed on a home computer and available to doctors via the Internet, indicates heart condition. The circuits provide signal triangulation verification and warning lights. The sensors may be located any place on the body, i.e. wrist bands, chest, head, etc. A transmitter sends signals to the circuitry on the glasses to display reading information and lights about heart condition, pulse rate and blood pressure. Circuits on the glasses process and display electrical signals, pressure signals, pulse rate signals and combinations thereof.
Owner:RIVAS TECH INT
Sensor guided epicardial lead
Implantable cardiac monitoring and stimulation methods and devices with epicardial leads having sensor feedback. A fixed or extendable / retractable sensor may be displaceable within the lead's lumen and configured to sense the presence of an anatomical feature or physiological parameter of cardiac tissue in proximity with the lead body's distal end. The sensor may include an ultrasonic sensing element, a perfusion sensor, a photoplethysmographic sensor, or a blood oximetry sensor. Methods of determining suitability for implanting a lead involve the steps of accessing an epicardial surface of the heart, and moving the cardiac lead to an implant site at the epicardial surface. A transmitted signal is directed at the implant site. A reflected signal is received, indicative of the presence of a blood vessel at the implant site. A determination may be made to determine whether the implant site is suitable or unsuitable based on the reflected signal.
Owner:CARDIAC PACEMAKERS INC
Separation of a subcutaneous cardiac signal from a plurality of composite signals
A cardiac monitoring and / or stimulation method and systems provide monitoring, defibrillation and / or pacing therapies, including systems detecting and / or treating cardiac arrhythmia. A system includes a housing coupled to a plurality of electrodes configured for subcutaneous non-intrathoracic sensing. A signal processor receives a plurality of composite signals associated with a plurality of sources, separates a signal from the plurality of composite signals using blind source separation, and identifies a cardiac signal. The signal processor may iteratively separate signals from the plurality of composite signals until the cardiac signal is identified. A method of signal separation includes detecting a plurality of composite signals at a plurality of locations, separating a signal using blind source separation, and identifying a cardiac signal. The separation may include a principal component analysis and / or an independent component analysis. The composite signals may be filtered before separation using band-pass filtering, adaptive, or other filters.
Owner:CARDIAC PACEMAKERS INC
Cardiac monitoring
ActiveUS7194300B2Improved positive predictabilityIncreased clinical significanceElectrotherapyElectrocardiographyPhysiological valuesCardiac monitoring
Systems and techniques for monitoring cardiac activity. In one aspect, a method includes collecting information describing the variability in heart rate over a series of beats, designating variability at a lower end of physiological values as being largely irrelevant to atrial fibrillation, designating variability in a midrange of physiological values as being indicative of atrial fibrillation, designating variability in an upper range of physiological values as being negatively indicative of atrial fibrillation, and determining a relevance of the variability described in the collection to atrial fibrillation.
Owner:BRAEMAR MFG
System and method for segmenting a cardiac signal based on brain stimulation
A medical device system that includes a brain stimulating element, cardiac monitoring element and a processor. The processor is configured to receive a brain stimulation signal from the brain stimulating element and a cardiac signal from the cardiac monitoring element. The processor is further configured to determine at least one reference point for a stimulation event time period by evaluation of the brain stimulation signal. The processor further identifies a first portion of the cardiac signal based on the at least one reference point of the stimulation event time period.
Owner:MEDTRONIC INC
Reconfigurable implantable cardiac monitoring and therapy delivery device
Methods and systems for implantable cardiac monitors reconfigurable to cardiac therapy devices. A device includes a housing with electrodes configured for cardiac activity sensing when the device is operated in monitoring mode, and sensing and energy delivery when operated in an energy delivery mode. A header may be configured to receive a cardiac lead, and may be associated with a switch to switch the device between monitoring and therapy modes in response to connecting one or more leads to the header. The device may include a transceiver that transmits the contents of the memory to a patient-external device. A method involves providing an implantable cardiac device configured to operate in a first mode as a loop recorder for monitoring cardiac activity and storing selected cardiac events, and operating in the second mode to monitor cardiac activity and provide cardiac stimulation therapy when the second mode is enabled.
Owner:CARDIAC PACEMAKERS INC
Subcutaneous cardiac signal discrimination employing non-electrophysiologic signal
A cardiac monitoring and / or stimulation system includes a housing coupled to a plurality of electrodes configured for subcutaneous non-intrathoracic sensing. A signal processor receives a plurality of composite signals associated with a plurality of sources, separates a signal from the plurality of composite signals, and identifies the separated signal as a cardiac signal using information derived from a non-electrophysiologic sensor, such as an accelerometer or acoustic transducer. The signal processor may iteratively correlate separated signals from the plurality of composite signals with a non-electrophysiologic sensor signal until the cardiac signal is identified.
Owner:CARDIAC PACEMAKERS INC
Mechanical function marker channel for cardiac monitoring and therapy control
The implantable medical device (IMD) system disclosed here utilizes one or more cardiac sensors that measure mechanical characteristics of the heart, such as left ventricular acceleration or right ventricular pressure. The raw sensor data is collected and processed by the IMD, which derives one or more mechanical event marker signals from features, traits, and characteristics of the sensor data waveforms. The mechanical event marker signals are wirelessly transmitted to an external monitor device for display.
Owner:MEDTRONIC INC
Closed loop cardiac resynchronization therapy using cardiac activation sequence information
Cardiac monitoring and / or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and / or trend closed-loop cardiac resynchronization therapy using cardiac activation sequence information. Devices and methods involve sensing a plurality of composite cardiac signals using a plurality of electrodes, the electrodes configured for implantation in a patient. A source separation is performed using the sensed plurality of composite cardiac signals, producing one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences. A cardiac resynchronization therapy is adjusted using one or both of the one or more cardiac signal vectors and the signals associated with the one or more cardiac signal vectors. In further embodiments, the cardiac resynchronization therapy may be initiated, terminated, or one or more parameters of the resynchronization therapy may be altered.
Owner:CARDIAC PACEMAKERS INC
Delivery of a sympatholytic cardiovascular agent to the central nervous system
A sympatholytic cardiovascular agent delivered by a drug delivery pump to a central nervous system site to alleviate symptoms of acute or chronic cardiac insult or impaired cardiac performance. The drug delivery pump can be external or implantable infusion pump (IIP) coupled with a drug infusion catheter extending to the site. A patient activator can command delivery of a dosage and / or an implantable heart monitor (IHM) coupled with a sensor can detect physiologic parameters associated with cardiac insult or impaired cardiac performance and trigger dosage delivery. The IIP and IHM can be combined into a single implantable medical device (IMD) or can constitute separate IMDs that communicate by any of known communication mechanisms. The sympatholytic cardiovascular agent is one of the group consisting of an alpha-adrenergic agonist and an alpha2-adrenergic agonist (e.g., clonidine, p-aminoclonidine, guanabenz, lidamidine, tizanidine, moxonidine, methyldopa, xylazine, guanfacine, detomidine, medetomidine, and dexmedetomidine).
Owner:MEDTRONIC INC
Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes
InactiveUS20060253164A1Heart stimulatorsDiagnostic recording/measuringImplantable ElectrodesCardiac monitoring
Cardiac monitoring and / or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed for automatic capture verification using cardiac activation sequence information. Devices and methods sense composite cardiac signals using implantable electrodes. A source separation is performed using the composite signals. One or more signal vectors are produced that are associated with all or a portion of one or more cardiac activation sequences based on the source separation. A cardiac response to the pacing pulses is classified using characteristics associated with cardiac signal vectors and the signals associated with the vectors. Further embodiments may involve classifying the cardiac response as capture or non-capture, fusion or intrinsic cardiac activity. The characteristics may include an angle or an angle change of the cardiac signal vectors, such as a predetermined range of angles of the one or more cardiac signal vectors.
Owner:CARDIAC PACEMAKERS INC
Posture monitoring using cardiac activation sequences
Cardiac monitoring and / or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and / or trend a patient's posture using cardiac activation sequence information. Devices and methods in accordance with the present invention involve sensing a plurality of composite cardiac signals using a plurality of implantable electrodes. A source separation is performed using the composite cardiac signals, which produces one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences. A change in a patient's posture is detected using the cardiac signal vectors. Further embodiments involve sensing the plurality of composite cardiac signals during the patient's predominant cardiac rhythm before detecting the change in the patient's posture. Other embodiments involve discriminating between one of a postural related change and a cardiac rhythm related change using the cardiac signal vectors.
Owner:CARDIAC PACEMAKERS INC
Delivery of a sympatholytic cardiovascular agent to the central nervous system to counter heart failure and pathologies associated with heart failure
A sympatholytic cardiovascular agent delivered by a drug delivery pump to a central nervous system site to alleviate symptoms and otherwise treat heart failure (HF) and pathologies associated with HF. The drug delivery pump can be external or implantable infusion pump (IIP) coupled with a drug infusion catheter extending to the site. A patient activator can command delivery of a dosage and / or an implantable heart monitor (IHM) coupled with a sensor can detect physiologic parameters associated with HF (or pathologies associated with HF) and trigger dosage delivery. The IIP and IHM can be combined into a single implantable medical device (IMD) or can constitute separate IMDs that communicate by any of known communication mechanisms. The sympatholytic cardiovascular agent is one of the group consisting of an alpha-adrenergic agonist and an alpha2-adrenergic agonist, e.g., clonidine, p-aminoclonidine, guanabenz, lidamidine, tizanidine, moxonidine, methyldopa, xylazine, guanfacine, detomidine, medetomidine, and dexmedetomidine.
Owner:MEDTRONIC INC
Systems and methods for interelectrode distance optimization in a retractable multi-use cardiac monitor
ActiveUS9226679B2Easy and function-enhancing adjustmentElectrocardiographySensorsEcg signalCardiac monitoring
Owner:MEDICOMP
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com